WO2007033366A3 - Biphenyl-pyrazolecarboxamide compounds - Google Patents

Biphenyl-pyrazolecarboxamide compounds Download PDF

Info

Publication number
WO2007033366A3
WO2007033366A3 PCT/US2006/036000 US2006036000W WO2007033366A3 WO 2007033366 A3 WO2007033366 A3 WO 2007033366A3 US 2006036000 W US2006036000 W US 2006036000W WO 2007033366 A3 WO2007033366 A3 WO 2007033366A3
Authority
WO
WIPO (PCT)
Prior art keywords
biphenyl
compositions
compounds
pyrazolecarboxamide compounds
pyrazolecarboxamide
Prior art date
Application number
PCT/US2006/036000
Other languages
French (fr)
Other versions
WO2007033366A8 (en
WO2007033366A2 (en
Inventor
Roger Tung
Original Assignee
Concert Pharmaceuticals Inc
Roger Tung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Concert Pharmaceuticals Inc, Roger Tung filed Critical Concert Pharmaceuticals Inc
Publication of WO2007033366A2 publication Critical patent/WO2007033366A2/en
Publication of WO2007033366A3 publication Critical patent/WO2007033366A3/en
Publication of WO2007033366A8 publication Critical patent/WO2007033366A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

The present invention relates to biphenyl-pyrazole compounds and in particular biphenyl-pyrazolecarboxamides. The invention further provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions beneficially treated by antagonism or inverse agonism of the CB1 receptor, such as obesity, smoking cessation, and normalization of blood lipid composition.
PCT/US2006/036000 2005-09-14 2006-09-14 Biphenyl-pyrazolecarboxamide compounds WO2007033366A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71755505P 2005-09-14 2005-09-14
US60/717,555 2005-09-14

Publications (3)

Publication Number Publication Date
WO2007033366A2 WO2007033366A2 (en) 2007-03-22
WO2007033366A3 true WO2007033366A3 (en) 2007-05-10
WO2007033366A8 WO2007033366A8 (en) 2008-02-28

Family

ID=37865603

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/036000 WO2007033366A2 (en) 2005-09-14 2006-09-14 Biphenyl-pyrazolecarboxamide compounds

Country Status (1)

Country Link
WO (1) WO2007033366A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090281143A1 (en) * 2007-12-10 2009-11-12 N-Gene Research Laboratories, Inc. Dose Reduction of a Cannabinoid CB1 Receptor Antagonist in the Treatment of Overweight or Obesity

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870095A (en) * 1988-06-13 1989-09-26 Sterling Drug, Inc. 1H-pyrazole-1-alkanamides, antiarrhythmic compositions and use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870095A (en) * 1988-06-13 1989-09-26 Sterling Drug, Inc. 1H-pyrazole-1-alkanamides, antiarrhythmic compositions and use

Also Published As

Publication number Publication date
WO2007033366A8 (en) 2008-02-28
WO2007033366A2 (en) 2007-03-22

Similar Documents

Publication Publication Date Title
WO2007016538A3 (en) Preparation and use of biphenyl amino acid derivatives for the treatment of obesity
WO2009002947A3 (en) Compounds and peptides that bind the trail receptor
WO2007008529A3 (en) Celullar cholesterol absorption modifiers
WO2006044775A3 (en) Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity
MX2010004219A (en) Cd19 binding agents and uses thereof.
TN2010000140A1 (en) Compositions and methods for use antibodies against sclerostin
WO2007120980A3 (en) 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
WO2008073933A3 (en) 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
UA101478C2 (en) Compounds useful as inhibitors of raf protein kinase
WO2006113919A3 (en) Aryl alkyl acid derivatives for and use thereof
WO2007008541A3 (en) Cellular cholesterol absorption modifiers
WO2007109279A3 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
MX2009006471A (en) Engineered anti-tslp antibody.
WO2008064351A3 (en) (r)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs
WO2008097640A8 (en) Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer
WO2007127791A3 (en) New pharmacological method for treatment of neuropathic pain
MX2009005935A (en) Chemical compounds and uses.
WO2007092622A3 (en) Compositions and methods for treating bone
WO2005086656A3 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
WO2008076754A3 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
WO2006012577A3 (en) Quinazolinone derivatives useful for the regulation of glucose homeostasis and food intake
WO2007075439A3 (en) Compositions and methods for treating obesity and related metabolic disorders
WO2008013987A3 (en) N-alkyl substituted piperazinylmethylquinazolinones and azepanylmethylquinazolinones
WO2007059154A3 (en) Treatment of cancers with acquired resistance to kit inhibitors
WO2009002423A3 (en) Polycyclic guanine derivatives and use thereof

Legal Events

Date Code Title Description
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06814730

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)